Enbiosis Biotechnology are thrilled to announce their participation in the upcoming Arab Health 2024.
In their recent partnership with Saudi Innova Health Care, their objective is to explore new opportunities in the MENA region.
As pioneers in the field, Enbiosis Biotechnology are dedicated to unraveling the complexity of the gut microbiome and its profound impact on human well-being and diseases. Leveraging the power of big data and artificial intelligence, Enbiosis Biotechnology has developed a clinically proven, cloud-based SaaS product that offers personalized food recommendations and precision supplements.
The human microbiome, particularly that of the gut, plays a crucial role in maintaining overall health, influencing digestion, nutrient absorption, immune system regulation, and even mental well-being. It plays a vital role in preventing diseases, supporting metabolism, and maintaining overall physiological balance. We at ENBIOSIS help you discover what is concealed within your gut to to support and maintain your overall health by harnessing the potential of microbiome organisms.
Enbiosis Biotechnology has garnered recognition through various accolades, including being honored as the UK Government's TechRocketship 2022 winner among 256 tech scale-up companies, achieving Sanofi Country Winner status, completing the Bayer Accelerator program, and winning the NN Insurance global competition. We take immense pride in being the first AI-based gut health solution with clinical validation.
Visit Enbiosis Biotechnology on booth, H2 G53, located within the ABHI UK Pavilion, at the Arab Health to witness firsthand how Enbiosis Biotechnology is revolutionising gut health through cutting-edge technology, proven results, and a commitment to excellence.
Enbiosis Biotechnology look forward to showcasing their groundbreaking solutions, being more active in the MENA region, and connecting with industry leaders, healthcare professionals, and stakeholders who share their passion for advancing human well-being.
